Table 6.

Pathological evaluation ofHelicobacter pylori virulence factor genotype status

	Antrum		Corpus
	High virulent factor	Low virulent factor	High virulent factor	Low virulent factor
Neutrophil infiltration	NA	NA	NA	NA
hopQ type I/type II	2.78 ± 0.10*	1.91 ± 0.12	2.02 ± 0.10*	1.38 ± 0.12
vacA s1m1/s2m2	2.70 ± 0.09*	1.74 ± 0.15	2.02 ± 0.09*	1.13 ± 0.16
cagA positive/negative	2.62 ± 0.08*	1.70 ± 0.16	1.89 ± 0.08*	1.17 ± 0.17
hopQ type1-vacA s1m1/type II-s2m2	2.79 ± 0.11*	1.73 ± 0.17	2.11 ± 0.11*	1.22 ± 0.18
hopQ type1-vacA m1/type II-m2	2.76 ± 0.10*	1.65 ± 0.17	2.03 ± 0.10*	1.16 ± 0.17
hopQ type1-vacA s1m1-cagA (+)/type II-s2m2-(−)	2.79 ± 0.11*	1.67 ± 0.17	2.11 ± 0.11*	1.23 ± 0.18
Atrophy	NA	NA	NA	NA
hopQ type I/type II	1.62 ± 0.13*	0.94 ± 0.16	1.26 ± 0.14*	0.79 ± 0.15
vacA s1m1/s2m2	1.73 ± 0.13*	0.80 ± 0.16	1.40 ± 0.13*	0.71 ± 0.19
cagA positive/negative	1.55 ± 0.11*	0.66 ± 0.16	1.22 ± 0.11*	0.62 ± 0.18
hopQ type1-vacA s1m1/type II-s2m2	1.68 ± 0.15*	0.64 ± 0.16	1.39 ± 0.15*	0.57 ± 0.17
hopQ type1-vacA m1/type II-m2	1.61 ± 0.14*	0.58 ± 0.15	1.25 ± 0.14*	0.57 ± 0.16
hopQ type1-vacA s1m1-cagA (+)/type II-s2m2-(−)	1.68 ± 0.15*	0.55 ± 0.16	1.39 ± 0.15*	0.55 ± 0.17

^*P < 0.05.